Article | September 27, 2021

Tips For Managing GMP Manufacturing Timelines

Source: OmniaBio
iStock-943557452-pharmaceutical-manufacturing-technician

Managing timelines is a shared challenge for contract development and manufacturing organizations (CDMOs) and their clients, with important implications for both parties. For cell and gene therapy developers, delays mean lost time and resources that can negatively impact the pathway to commercialization for their products. For CDMOs, delays impact capacity and resource planning.

CDMOs and their clients must work to understand and mitigate timeline risks so that there is minimal impact on project success. A CDMO’s project management (PM) team will be the client’s main partner in developing and managing timelines and holding various internal and external stakeholders accountable. Where needed, the PM team also serves to facilitate an escalation path to help resolve challenges. In this post, we will outline how the PM team can help manage timelines and avoid delays.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene